GlassScriptPhysician profile
Jeanne Novas
NPI 1235160433
$2,465.74
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $788 · 2020: $433 · 2021: $366 · 2022: $675 · 2023: $58.47 · 2024: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $204.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $226.74 | 2019-2024 | |
| Amgen INC. | $221.02 | 2019-2022 | |
| Currax Pharmaceuticals LLC | $216.80 | 2020-2022 | |
| Allergan, INC. | $210.76 | 2019-2022 | |
| Therapeuticsmd, INC. | $185.12 | 2019-2022 | |
| Novo Nordisk INC | $180.48 | 2019-2023 | |
| Pfizer INC. | $167.43 | 2019-2022 | |
| Organon LLC | $129.90 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $121.83 | 2024 | Farxiga |
| Vertiflex, INC. | $109.86 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $83.21 | 2019-2022 | |
| Lupin INC. | $79.08 | 2019-2020 | |
| Duchesnay USA Incorporated | $75.57 | 2019 | |
| Gynesonics, INC. | $71.00 | 2022 | |
| Agile Therapeutics, INC. | $65.32 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $60.26 | 2019-2022 | |
| Bard Access Systems, INC. | $43.03 | 2019 | |
| Mayne Pharma Commercial LLC | $41.59 | 2021-2022 | |
| Astellas Pharma US INC | $31.90 | 2019-2020 | |
| Minerva Surgical, INC | $27.97 | 2021-2022 | |
| Mission Pharmacal Company | $23.68 | 2019-2020 | |
| Hologic Sales and Service, LLC | $23.41 | 2019 | |
| Ferring Pharmaceuticals INC. | $19.88 | 2019 | |
| Merck Sharp & Dohme LLC | $18.08 | 2021 | |
| Boston Scientific Corporation | $17.58 | 2019 | |
| Avion Pharmaceuticals | $14.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeanne Novas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.